Sêmaxx Nasal Spray — Research Compound Formulation

Sêmaxx Nasal Spray — Research Compound Formulation For Laboratory and Research Use Only — Not for Human Consumption Overview Sêmaxx Nasal Spray is a research-grade formulation developed by Qualitide, combining two synthetic peptide compounds — Sêmax and Sêlank — into a single intranasal delivery format designed for laboratory and investigational research. Both compounds have been the subject of scientific literature for several decades, primarily originating from research programs in Russia and Eastern Europe, where they were initially developed and studied under different regulatory frameworks than exist in the United States. Qualitide formulated Sêmaxx to give researchers a standardized, quality-controlled combination product for studying the two peptides’ properties, either independently or in combination, within appropriate research settings. This product is manufactured to research-grade specifications and is not approved by the FDA or any other regulatory body for diagnostic, therapeutic, or human use.